Beyond insulin secretion, verapamil and other CCBs reduce the β-cell expression of thioredoxin-interacting protein (TXNIP), a proapoptotic factor overexpressed in diabetes, thereby inhibiting β-cell apoptosis and enhancing survival [44]. Here, TXNIP is linked to diabetes mellitus.